Dealroom maps Bicycle Therapeutics's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

6 standout operatorsDealroom-flagged across the org

8 AI specialistsincl. 2 core researchers

271 employees mappedperson by person

DimensionScore

AI Talentlive

Engineering

Product

Go-to-market

Leadership

Research

Book a demo to unlock Bicycle Therapeutics's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Patent intelligence

$117M patent portfolio · 75 active families

Estimated portfolio value

$117M

3.9× larger than top peer Day One Biopharmaceuticals ($30M)

75 active patent families

Where Bicycle Therapeutics innovates CarcinosisCovalent modifierCyclic peptideDiseaseEffector

Where Bicycle Therapeutics concentrates vs peers

Each axis is a top-10 topic across Bicycle Therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Bicycle Therapeutics

An AI-synthesized read of the highest-engagement posts about Bicycle Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Bicycle Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles